|
|
Please log in to edit this profile
|
| Elevator Pitch |
Juvaris BioTherapeutics, Inc. is developing novel, adjuvanted vaccines and immunotherapeutics to treat infectious disease and cancer. Juvaris has been funded primarily from the venture capital firm Kleiner Perkins Caufield & Byers. |
| Industry Focus |
BioPharma |
| Category |
Companies - Expansion Stage |
| Location |
866 Malcolm Road, Suite 100 |
|
Burlingame, California
94010
|
|
United States |
| |
| Phone |
(650) 259-1800 |
| Fax |
(650) 697-8828 |
| Email |
Please log in |
| Web |
http://www.juvaris.com |
|
|
|
Amount: $25,000,000
Closed: September 17, 2009
|
|
|
|
|
|
|
Round: Series B
Amount: Unspecified
Closed: September, 2009
|
|
|
|
|
|
|
Round: Series B
Amount: Unspecified
Closed: September, 2009
|
|
|
|
| Be the first to recommend Juvaris!
Log in |
Public information, member edits, and the DealHorizon.com team.
|
Office Location
Statistics
Search Site
Edit/Update
Followers
Please log in
Note: Once associated with a listing, Executives are automatically included as followers of that listing. Listing
creators are also automatically added as followers.
|
